Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Lukas Biomedical Logo
Lukas Biomedical Growth Score
88
CB Rank
612631
Heat Score
58
Lukas Biomedical engages in the research and development of immunotherapy for cancer treatment.
Founded
obfuscation
Private Taipei, T'ai-pei, Taiwan11-50 www.lukas-bio.com.tw
Biotechnology
Life Science
Medical
Oncology
Therapeutics
Overview

Lukas Biomedical
Growth Score
88
Heat Score
58

Growth Score88
-2 pts
in past quarter
Heat Score 58
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Lukas Biomedical

CB Rank
612631
Lukas Biomedical engages in the research and development of immunotherapy for cancer treatment.
Founded
obfuscation
Private Taipei, T'ai-pei, Taiwan11-50 www.lukas-bio.com.tw
Biotechnology
Life Science
Medical
Oncology
Therapeutics

Details

Legal Name LUKAS BIOMEDICAL INC
Also Known As Lujia Biomedical
Operating Status Active
Company Type For Profit
Phone Number +8862 2950-0027
Contact Email service@lukas-biomedical.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Memory T Cell Immunotherapy
A cancer treatment using cultured memory T cells to target and kill tumor cells, enhancing immune response against cancer.
neo-LuLym Tumor Antigen Analysis and Cultivation Technology
A technology that analyzes tumor antigens and cultivates dendritic cells with T cells to enhance targeted immune response against cancer.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News
Technology
View Tech Report

Active Website Tech Count

9Lukas Biomedical is actively using 9 technologies for its website, according to BuiltWith. These include Euro, Google Maps, and  Google Cloud.

Total IP

1Lukas Biomedical has 1 registered trademark in the 'Bleaching, cleaning, polishing, scouring and abrasive preparations; cosmetics' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Lukas Biomedical's headquarters? Lukas Biomedical is located in Taipei, T'ai-pei, Taiwan.Who are Lukas Biomedical's competitors? Alternatives and possible competitors to Lukas Biomedical may include Allotera Therapeutics, Caribou Biosciences, and  Iovance Biotherapeutics.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5d42803 1)
|